Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1265 | 8379 | 39.0 | 81% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
758 | 3011 | CHRONIC LYMPHOCYTIC LEUKEMIA//CLL//B CLL |
3441 | 1907 | FLUDARABINE//CHRONIC LYMPHOCYTIC LEUKEMIA//CLADRIBINE |
6136 | 1460 | HAIRY CELL LEUKEMIA//HAIRY CELL LEUKAEMIA//HAIRY CELL LEUKEMIA VARIANT |
6639 | 1389 | CD20//OFATUMUMAB//OBINUTUZUMAB |
20470 | 397 | T CELL PROLYMPHOCYTIC LEUKEMIA//T PLL//TCL1 |
26196 | 215 | BENDAMUSTINE//TREANDA//BENDAMUSTIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHRONIC LYMPHOCYTIC LEUKEMIA | Author keyword | 722 | 50% | 12% | 1031 |
2 | HAIRY CELL LEUKEMIA | Author keyword | 449 | 73% | 4% | 338 |
3 | CLL | Author keyword | 434 | 54% | 7% | 566 |
4 | CHRONIC LYMPHOCYTIC LEUKAEMIA | Author keyword | 186 | 48% | 3% | 283 |
5 | FLUDARABINE | Author keyword | 167 | 39% | 4% | 337 |
6 | B CLL | Author keyword | 161 | 51% | 3% | 227 |
7 | CLADRIBINE | Author keyword | 134 | 51% | 2% | 186 |
8 | BENDAMUSTINE | Author keyword | 119 | 59% | 2% | 133 |
9 | 2 CHLORODEOXYADENOSINE | Author keyword | 90 | 60% | 1% | 100 |
10 | ZAP 70 | Author keyword | 88 | 51% | 1% | 123 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHRONIC LYMPHOCYTIC LEUKEMIA | 722 | 50% | 12% | 1031 | Search CHRONIC+LYMPHOCYTIC+LEUKEMIA | Search CHRONIC+LYMPHOCYTIC+LEUKEMIA |
2 | HAIRY CELL LEUKEMIA | 449 | 73% | 4% | 338 | Search HAIRY+CELL+LEUKEMIA | Search HAIRY+CELL+LEUKEMIA |
3 | CLL | 434 | 54% | 7% | 566 | Search CLL | Search CLL |
4 | CHRONIC LYMPHOCYTIC LEUKAEMIA | 186 | 48% | 3% | 283 | Search CHRONIC+LYMPHOCYTIC+LEUKAEMIA | Search CHRONIC+LYMPHOCYTIC+LEUKAEMIA |
5 | FLUDARABINE | 167 | 39% | 4% | 337 | Search FLUDARABINE | Search FLUDARABINE |
6 | B CLL | 161 | 51% | 3% | 227 | Search B+CLL | Search B+CLL |
7 | CLADRIBINE | 134 | 51% | 2% | 186 | Search CLADRIBINE | Search CLADRIBINE |
8 | BENDAMUSTINE | 119 | 59% | 2% | 133 | Search BENDAMUSTINE | Search BENDAMUSTINE |
9 | 2 CHLORODEOXYADENOSINE | 90 | 60% | 1% | 100 | Search 2+CHLORODEOXYADENOSINE | Search 2+CHLORODEOXYADENOSINE |
10 | ZAP 70 | 88 | 51% | 1% | 123 | Search ZAP+70 | Search ZAP+70 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CD38 EXPRESSION | 820 | 76% | 7% | 583 |
2 | CLL | 636 | 70% | 6% | 526 |
3 | GENOMIC ABERRATIONS | 434 | 76% | 4% | 304 |
4 | ZAP 70 EXPRESSION | 415 | 79% | 3% | 269 |
5 | VARIABLE REGION MUTATIONS | 388 | 88% | 2% | 183 |
6 | GENE MUTATION STATUS | 308 | 80% | 2% | 189 |
7 | FLUDARABINE | 274 | 39% | 7% | 555 |
8 | FLUDARABINE PLUS CYCLOPHOSPHAMIDE | 273 | 79% | 2% | 177 |
9 | CHRONIC LYMPHOCYTIC LEUKEMIA | 266 | 15% | 19% | 1615 |
10 | 2 CHLORODEOXYADENOSINE | 200 | 53% | 3% | 266 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYTOMETRY PART B-CLINICAL CYTOMETRY | 7 | 10% | 1% | 63 |
2 | HEMATOLOGY AND CELL THERAPY | 3 | 12% | 0% | 23 |
3 | HEMATOLOGY JOURNAL | 1 | 10% | 0% | 13 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines | 2008 | 939 | 63 | 87% |
Mechanisms of disease: Chronic lymphocytic leukemia | 2005 | 763 | 100 | 66% |
From pathogenesis to treatment of chronic lymphocytic leukaemia | 2010 | 197 | 147 | 76% |
Progress in the treatment of elderly/unfit chronic lymphocytic leukemia patients: results of the German CLL-11 trial | 2015 | 3 | 23 | 91% |
CURRENT CONCEPTS - CHRONIC LYMPHOCYTIC-LEUKEMIA | 1995 | 496 | 46 | 83% |
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus | 2007 | 174 | 37 | 97% |
From the bench to the bedside: ways to improve rituximab efficacy | 2004 | 303 | 94 | 68% |
A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia | 2015 | 2 | 25 | 80% |
Chronic lymphocytic leukaemia | 2008 | 142 | 146 | 88% |
Role of miR-15/16 in CLL | 2015 | 4 | 44 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HCT UNIT | 38 | 62% | 0.5% | 40 |
2 | CLIN EXPT ONCOHEMATOL UNIT | 31 | 67% | 0.3% | 28 |
3 | LEUKEMIA | 29 | 11% | 2.9% | 244 |
4 | CELL NEOPLASIA B | 18 | 67% | 0.2% | 16 |
5 | CLIN UNIT LYMPHOID MALIGNANCIES | 15 | 82% | 0.1% | 9 |
6 | FLOW IMAGE CYTOMETRY SECT | 15 | 82% | 0.1% | 9 |
7 | HAEMATOL CYTOGENET | 15 | 33% | 0.4% | 37 |
8 | AOUS | 15 | 68% | 0.2% | 13 |
9 | CLL CONSORTIUM | 15 | 77% | 0.1% | 10 |
10 | MAGGIORE GEN HOSP | 12 | 86% | 0.1% | 6 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000015943 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
2 | 0.0000010564 | DEOXYCYTIDINE KINASE//PURINE NUCLEOSIDE PHOSPHORYLASE//NUCLEOSIDE TRANSPORT |
3 | 0.0000009863 | FCRN//NEONATAL FC RECEPTOR//FC GAMMA RECEPTORS |
4 | 0.0000008239 | THYMUS//THYMIC NURSE CELLS//INTERLEUKIN 2 RECEPTOR |
5 | 0.0000007610 | MULTIPLE MYELOMA//THALIDOMIDE//MYELOMA |
6 | 0.0000007215 | CD40//BAFF//CD40 LIGAND |
7 | 0.0000006919 | RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM |
8 | 0.0000006435 | SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION |
9 | 0.0000006291 | HLA B8 DR3//INTERDISCIPLINARY STUDIES SECT//AH 81 |
10 | 0.0000005635 | MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA |